1[1]EDGLNGTON TS,MACKMAN N,BRAND K,et al.The structural biology of expression and function of tissue factor[J].Thromb Haemost,1991,66(1):67-79.
2[2]BACH RR.Mechanism of tissue factor activation on cells.Blood Coagulation and Fibrinolysis[J].Blood Coagul Fibrinolysis,1998,9(suppl 1):s37-43.
3[3]WOLBERG AS,MONROE DM,ROBERTS HR,et al.Tissue factot de-eneryption:ionophore treatment induces changes in tissue factor by phosphatidylserine-dependent and independent mechanisms[J].Blood Coagul Fibrinolysis,1999,10(4):201-210.
4[4]MORRISSEY JH.Tissue factor:an enzyme cofaetor and a true receptor[J].Thromb Haemost,2001,86(1):66-74.
5[5]RIVERS RPA,HATHAWAY WE,WETSON WL.The endotoxininduced coagulant activity of human monocytes[J].Br J Haematol,1975,30(3):311-316.
6[6]CIRILLO P,GOLINO P,CALABR P,et al.C-reactive protein induces tissue factor expression and promotes smooth muscle and endotheiial cell proliferation[J].Cardiovase Res,2005,68(1):47-55.
7[7]REVERTER JC,TASSIES D,FONT J,et al.Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes[J].Arthritis Rheum,1998(8),41:1420-1427.
8[8]CONKLING PR,GREENBERG CS,WEINBERG JB.Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes[J].Blood,1988,72(1):128-133.
9[9]GUAN M,JIN J.Tissue factor expression and angiogenesis in human glioma[J].Clin Biochem,2002,35(4):321-325.
10[10]NITORI N,INO Y,NAKANISHI Y,et al.Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma[J].Clin Cancer Res,2005,11(7):2531-2539.
2BrombergME, SundaramR, HomerRJ,et al. Role of TF in metastasis: functions of the cytoplasmic and extracellular domains of the molecule. Thromb Haemost, 1999,82: 88-92.
3Mueller BM, Ruf W. Requirement for binding of catalytically active factor Ⅶ a in TF-dependent experimental metastasis. J Clin Invest, 1998,101:1372-1378.
4Taniguchi T, Kakkar AK, Tuddenham EG, et al. Enhanced expression of urokinase receptor induced through the TF-factor Ⅶ a pathway in human pancreatic cancer. Cancer Res, 1998,58 : 4461-4467.
5Chen J, Bierhaus A, Schiekofer S,et al. TF--a receptor involved in the control of cellular properties, including angiogenesis. Thromb Haemost, 2001,86: 334-345.
6Barinaga M. Designing therapies that target tumor blood vessels.Science, 1997, 275: 482-484.
7Rickles FR, Shoji M, Abe K. The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: TF is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer. Int J Hematol, 2001,73:145-150.
